drugset / Trial / NCT00471380
A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension
RandomizedCrossoverDouble-blindTreatment
Summary
Double blind, crossover randomized, multicentric study to compare efficacy and tolerability of concomitant administration of travoprost and brinzolamide versus timolol-dorzolamide fixed combination in patients with glaucoma or ocular hypertension
Timeline
- Start
- 2007-03
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Brinzolamide | Small molecule | 1 % | Other |
| Comparator | Dorzolamide | Small molecule | 2 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |
| Comparator | Travoprost | Other / unclassified | 0.004 % | Other |